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Introduction: Case reports have been a long held tradition within the surgical literature. Reporting
guidelines can improve transparency and reporting quality. However, recent consensus-based guidelines
for case reports (CARE) are not surgically focused. Our objective was to develop surgical case report
guidelines.
Methods: The CARE statement was used as the basis for a Delphi consensus. The Delphi questionnaire
was administered via Google Forms and conducted using standard Delphi methodology. A multidisci-
plinary group of surgeons and others with expertise in the reporting of case reports were invited to
participate. In round one, participants stated how each item of the CARE statement should be changed
and what additional items were needed. Revised and additional items from round one were put forward
into a further round, where participants voted on the extent of their agreement with each item, using a
nine-point Likert scale, as proposed by the Grading of Recommendations, Assessment, Development and
Evaluations (GRADE) working group.
Results: In round one, there was a 64% (38/59) response rate. Following adjustment of the guideline with
the incorporation of recommended changes, round two commenced and there was an 83% (49/59)
response rate. All but one of the items were approved by the participants, with Likert scores 7e9
awarded by >70% of respondents. The ﬁnal guideline consists of a 14-item checklist.
Conclusion: We present the SCARE Guideline, consisting of a 14-item checklist that will improve the
reporting quality of surgical case reports.
© 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medical case reports have been popular since the time ofery, Guy's and St. Thomas' NHS Fo
dix at the end of this paper.
by Elsevier Ltd. This is an open accHippocrates [1]. With the rise of evidence-based medicine (EBM)
and their designation as level ﬁve evidence, their importance has
decreased as focus has shifted to higher levels of evidence, such asundation Trust, Westminster Bridge Road, London, SE1 7EH, UK.
ess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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inherent in looking at a single patient or even a case series, and are
hence able to answer research questionswith less inherent bias and
more reliably e if conducted well. Some even feared the extinction
of case reports due to low citation rates, negative effects on journal
impact factor and restricted page budgets [2,3]. As a result, many
journals have stopped publishing case reports altogether [2,4].
The rise of open access and electronic publishing has revived the
humble case report, with the launch of new journals dedicated to
publishing them [4]. In 2015, International Journal of Surgery (IJS)
Case Reports (www.casereports.com) became the largest publisher
of surgical case reports globally, according to Scopus® (www.
scopus.com).
Vandenbrouke has discussed the contribution of case reports to
medical progress: “they permit discovery of new diseases and unex-
pected effects (adverse or beneﬁcial) as well as the study of mecha-
nisms, and they play an important role in medical education. Case
reports and series have a high sensitivity for detecting novelty and
therefore remain one of the cornerstones of medical progress; they
provide many new ideas in medicine”.[5].
Case reports have speciﬁc relevance in the surgical literature.
The IDEAL recommendations call for structured case reports for
reporting a “ﬁrst-in-man” study e i.e. the ﬁrst time a new surgical
technique is used, in stage 1 of their framework [6,7]. This has been
exempliﬁed in recent times by case reports of facial transplantation
and other innovative techniques [8].
The Case Report or CARE Guidelines were developed in 2013 to
provide a framework that supports transparency and accuracy in
the publication of case reports and the reporting of information
from patient encounters [9]. They have been adopted by multiple
journals, and compliancewith them has beenmandatory at IJS Case
Reports. However, they are not tailored to surgery. In the authors
experience, the corollary is that peer-reviewers often focus on
what's missing, rather than what's actually present within the
manuscript. Our experience of over 3000 case reports informs us
that surgical case reports have speciﬁc reporting requirements that
need to be recognised in an adapted reporting guideline based on
CARE. The objective of this research was to conduct a Delphi
consensus exercise among experienced case report reviewers and
editors to develop the Surgical CAse REport (SCARE) Guidelines.1.1. Developing the SCARE guideline
We published our research protocol in advance [10]. In sum-
mary, we used the existing CARE guidelines as a starting point,
together with the Delphi consensus exercise approach. We issued a
survey using Google Forms (https://www.google.co.uk/forms/
about) asking participants in round one how each item of the
CARE guidelines should be changed, and gave an opportunity to
provide free text feedback. Following analysis of this information
from round one, the 13 items of the CARE guidelines were adjusted
as indicated by the participants.
In a subsequent round, participants were asked to rate their
level of agreement with the revised item and any additional items
that were suggested using a nine-point Likert scale and method-
ology as proposed by the GRADE group [11,12]. In this scale 1 to 3
signiﬁes an outcome of limited importance, 4 to 6 important but
not critical, and 7 to 9 critical. If 70% or more of respondents scored
an item 7 to 9 and fewer than 15% scored it 1 to 3, that item pro-
ceeded into the reporting guideline. Similarly, consensus that an
outcome should not be included was 70% or more scoring it 1 to 3
and 15% or less scoring it 7 to 9. The entire process was conductedelectronically and there were no pre-determined number of Delphi
rounds.1.2. Participant selection
Surgeons and others with signiﬁcant experience in reviewing or
editing case reports were selected. They were drawn from the
reviewer pool of IJS Case Reports (the top 150 were invited) as well
as thosewho havewritten on the topic of case reports or case series
in the past or who were recommended by Professor Douglas Alt-
man e who pioneered the CONSORT guideline. In total, 59 partic-
ipants agreed to the invitation to participate in this study,
representing 21 countries and all ten surgical specialties as well as
allied specialties including; dermatology, pathology, oncology,
clinical pharmacology, acute care surgery, with many participants
also occupying positions on journal editorial boards [13].2. Results
A pilot study was conducted prior to round one to check the
participants understanding of the questions. This involved 15/59
(25%) participants completing the survey before it went out to the
remainder of the group. The only change made following this was
to include a ﬁeld for name, so that the author could see who
actually completed the survey and therefore who needed to be
reminded. Therewas no evidence of misinterpretation or confusion
with the survey. In round one, there was a 64% (38/59) response
rate. The consensus view together with participant responses are
integrated into Table 1.
Following adjustment of the guideline with incorporation of
recommended changes, round two commenced. There was an 83%
(49/59) response rate. All items were approved by the participants
with Likert scores 7e9 awarded by>70% of respondents, apart from
item 12, which had 63%. Given that this is in the original guideline
and is optional i.e. “when appropriate”, it has carried over to the
SCARE guideline.2.1. SCARE guideline
Table 2 constitutes the SCARE guideline, and this is provided
again in an appendix, together with a column in which the author
can state the page number onwhich the criterion was achieved. All
authors submitting surgical case reports should also submit a
completed SCARE checklist with their manuscript and also state
explicitly in their report that they have complied with the SCARE
guideline, which they can cite. The guideline represents the mini-
mum that should be reported, and authors are encouraged to
provide additional details they deem relevant to the understanding
of the case.2.2. Endorsement
The SCARE guideline has been endorsed by the IJS Case Reports,
which publishes more surgical case reports than any other journal
according to the SCOPUS® abstracting and indexing service. It has
also been endorsed by Annals of Medicine and Surgery and IJS
Open, IJS Oncology, and IJS Short Reports (all part of IJS Publishing
Group Ltd) as well as Annals of Vascular Surgery. The authors hope
that more journals will endorse the guideline in due course.
Table 1
CARE Guidelines and round one responses.
Topic Item Checklist item description Responses (n ¼ 38)
Title 1 The words “case report” should be in the title along with the area of
focus
No Change 92% (35/38)
Key Words 2 2 to 5 key words that identify areas covered in this case report No Change 87% (33/38)
Abstract 3a IntroductiondWhat is unique about this case? What does it add to the
medical literature?
No Change 92% (35/38)
3b The main symptoms of the patient and the important clinical ﬁndings
3c The main diagnoses, therapeutic interventions, and outcomes
3d ConclusiondWhat are the main “take-away” lessons from this case?
Introduction 4 One or two “Paragraphs” summarizing why this case is unique or
educational, with references
No Change 89% (34/38)
Patient Information 5a De-identiﬁed demographic information and other patient speciﬁc
information
No major change 92% (35/38) but speciﬁcally add patient
age, sex, ethnicity, occupation and hand dominance if
relevant.
Add drug history.
5b Main concerns and symptoms of the patient
5c Medical, family, and psychosocial history including relevant genetic
information (also see timeline)
5d Relevant past interventions and their outcomes
Clinical Findings 6 Describe the relevant physical examination (PE) and other signiﬁcant
clinical ﬁndings
No Change 89% (34/38)
Timeline 7 Important information from the patient's history organized as a timeline No Change 79% (30/38)
“No need for timeline”
“delay from presentation to surgery should be reported”
Diagnostic
Assessment
8a Diagnostic methods (such as PE, laboratory testing, imaging, surveys) No Change 89% (34/38)
Spell out “PE” (i.e. physical exam). Add histopathology and
radiological images.
8b Diagnostic challenges (such as access, ﬁnancial, or cultural)
8c Diagnostic reasoning including other diagnoses considered
8d Prognostic characteristics (such as staging in oncology) where
applicable
Therapeutic
Intervention
9a Types of intervention (such as pharmacologic, surgical, preventive, self-
care)
Changes 53% (20/38)
“What time periods”
“Postoperative surgical stay.”
“Need to stress patient reported outcome measures”
“Describe concurrent treatments (antibiotics, analgesics,
nill-per-os, etc.)”
“What was done, when it was done, and how it was done.
Focus on the decision making process in case of
intervention”
“Surgical technique and used materials”
“1. particular surgical tools or need for equipment 2. the
level of difﬁculty of the surgery, 3. anticipated learning
curve, 4. similarity to other procedures (may be too obvious
to be worth mentioning). 5. For e.g. (cutaneous) laser
surgery dosing, i.e. number of treatments and settings of the
laser, information that informs the setting e.g. skin type 6.
anticipated complications and caution 7. backup teams, can
it be done ambulatory? 8. information about post surgery
care, post surgery disability, specialty needs, and special
wound care needs facilitate replication”
“Types of intervention (non-operative, operative, minimally
invasive, endovascular, endoscopic, preventive)”
“Whywas that speciﬁc operation chosen? Is it an innovative
operation? (Explain rationale and peculiar technical
aspects). Are new devices used? (Describe them). Were
there any unexpected outcomes?(Unpredicted
histology,very rare intraoperative surgical complications).”
9b Administration of intervention (such as dosage, strength, duration)
9c Changes in intervention (with rationale)
Follow-up and
Outcomes
10a Clinician and patient-assessed outcomes (when appropriate) Changes 71% (27/38)
“Future surveillance requirements - e.g. EVAR”
“Some items like blood loss, operative time, wound
complications, re-exploration/revision surgery, 30-day
post-op morbidity may need to be speciﬁed.”
“How were complications prevented, diagnosed and
managed.”
10b Important follow-up diagnostic and other test results
10c Intervention adherence and tolerability (How was this assessed?)
10d Adverse and unanticipated events
Discussion 11a Discussion of the strengths and limitations in your approach to this case No change 87% (33/38)
“Contraindications for the procedure”
“Any new hypothesis generating ﬁndings?”
“Potential patient risk and possible complication if new
description of surgical technique or implant.”
11b Discussion of the relevant medical literature
11c The rationale for conclusions (including assessment of possible causes
11d The primary “take-away” lessons of this case report
Patient Perspective 12 When appropriate the patient should share their perspective on the
treatments they received
No change 89% (34/38)
Informed Consent 13 Did the patient give informed consent? Please provide if requested No change 97% (37/38)
Additional items Acknowledgement section; competing interests; ethics committee or
institutional review board approval where appropriate.
The setting in which the case was done: academic, community or
private practice setting?
Limitations of the case report
Patient optimization pre-op
Changes 47% (18/38) but no comments speciﬁcally given.
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Table 1 (continued )
Topic Item Checklist item description Responses (n ¼ 38)
Any radiological ﬁgures or pathological sections, intraoperative ﬁndings
photos, endoscopic images.
Table 2
Delphi Round two responses e items included here constitute the ﬁnal SCARE guideline.
Topic Item Checklist item description n ¼ 49, scores 7-9
Title 1 The words “case report” and the area of focus should appear in the title (e.g. presentation,
diagnosis, surgical technique or device or outcome)
94% (46/49)
Key Words 2 3 to 6 key words that identify areas covered in this case report (include “case report” as one
of the keywords)
78% (38/49)
Abstract 3a IntroductiondWhat is unique or educational about the case? What does it add to the
surgical literature? Why is this important?
98% (48/49)
3b The patient's main concerns and important clinical ﬁndings.
3c The main diagnoses, therapeutic interventions, and outcomes.
3d Conclusion d what are the “take-away” lessons from this case?
Introduction 4 A summary of why this case is unique or educational with reference to the relevant surgical
literature and current standards of care (with references, 1e2 paragraphs). Nature of the
institution in which the patient was managed; academic, community or private practice
setting?
88% (43/49)
Patient Information 5a De-identiﬁed demographic and other patient speciﬁc information including age, sex,
ethnicity, occupation and other useful pertinent information e.g. BMI and hand dominance.
90% (44/49)
5b Presentation, including presenting complaint and symptoms of the patient as well as the
mode of presentation e.g. brought in by ambulance or walked into Emergency Room or
referred by family physician.
5c Past medical and surgical history and relevant outcomes from interventions
5d Drug history, family history, including any relevant genetic information, and psychosocial
history, including smoking status and where relevant accommodation type, walking aids,
etc.
Clinical Findings 6 Describe the relevant physical examination and other signiﬁcant clinical ﬁndings (include
clinical photographs where relevant and where consent has been given).
98% (48/49)
Timeline 7 Inclusion of data which allows readers to establish the sequence and order of events in the
patient's history and presentation (using a table or ﬁgure if this helps). Delay from
presentation to intervention should be reported.
90% (44/49)
Diagnostic Assessment 8a Diagnostic methods (physical exam, laboratory testing, radiological imaging, histopathology
etc).
94% (46/49)
8b Diagnostic challenges (access, ﬁnancial, cultural).
8c Diagnostic reasoning including other diagnoses considered
8d Prognostic characteristics when applicable (e.g. tumour staging). Include relevant
radiological or histopathological images in this section (the latter may sometimes be better
placed in section 9).
Therapeutic Intervention 9a Pre-intervention considerations e.g. Patient optimisation: measures taken prior to surgery
or other intervention e.g. treating hypothermia/hypovolaemia/hypotension in a burns
patient, ICU care for sepsis, dealing with anticoagulation/other medications, etc
92% (45/49)
9b Types of intervention(s) deployed and reasoning behind treatment offered
(pharmacological, surgical, physiotherapy, psychological, preventive) and concurrent
treatments (antibiotics, analgesia, anti-emetics, nil by mouth, VTE prophylaxis, etc). Medical
devices should have manufacturer and model speciﬁcally mentioned.
9c Peri-intervention considerations - administration of intervention (what, where, when and
how was it done, including for surgery; anaesthesia, patient position, use of tourniquet and
other relevant equipment, prep used, sutures, devices, surgical stage (1 or 2 stage, etc).
Pharmacological therapies should include formulation, dosage, strength, route, duration.
9d Who performed the procedure - operator experience (position on the learning curve for the
technique if established, specialisation and prior relevant training).
9e Any changes in the interventions with rationale. Include intra-operative photographs and/or
video or relevant histopathology in this section. Degree of novelty for a surgical technique/
device should be mentioned e.g. “ﬁrst in-human”.
9f Post-intervention considerations e.g. post-operative instructions and place of care.
Follow-up and Outcomes 10a Clinician assessed and patient-reported outcomes (when appropriate) should be stated with
inclusion of the time periods at which assessed. Relevant photographs/radiological images
should provided e.g. 12 month follow-up.
94% (46/49)
10b Important follow-up measures - diagnostic and other test results. Future surveillance
requirements - e.g. imaging surveillance of endovascular aneurysm repair (EVAR) or clinical
exam/ultrasound of regional lymph nodes for skin cancer.
10c Where relevant - intervention adherence and tolerability (how was this assessed).
10d Complications and adverse or unanticipated events. Described in detail and ideally
categorised in accordance with the Clavien-Dindo Classiﬁcation. How they were prevented,
diagnosed and managed. Blood loss, operative time, wound complications, re-exploration/
revision surgery, 30-day post-op and long-term morbidity/mortality may need to be
speciﬁed.
Discussion 11a Strengths, weaknesses and limitations in your approach to this case. For new techniques or
implants - contraindications and alternatives, potential risks and possible complications if
98% (48/49)
(continued on next page)
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Table 2 (continued )
Topic Item Checklist item description n ¼ 49, scores 7-9
applied to a larger population. If relevant, has the case been reported to the relevant national
agency or pharmaceutical or devices company (e.g. an adverse reaction to a device).
11b Discussion of the relevant literature, implications for clinical practice guidelines and any
relevant hypothesis generation.
11c
The rationale for your conclusions.
11d The primary “take-away” lessons from this case report.
Patient Perspective 12 When appropriate the patient should share their perspective on the treatments they
received.
63% (31/49)
Informed Consent 13 Did the patient give informed consent for publication? Please provide if requested by the
journal/editor. If not given by the patient, explain why e.g. death of patient and consent
provided by next of kin or if patient/family untraceable then document efforts to trace them
and who within the hospital is acting as a guarantor of the case report.
80% (39/49)
Additional Information 14 Conﬂicts of Interest, sources of funding, institutional review board or ethics committee
approval where required/appropriate.
84% (41/49)
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The SCARE Statement is a consensus-based guideline following
two Delphi rounds among a multidisciplinary and expert group in
the area of surgery and case reports. We hope that surgeons and
surgical journals will adopt them. We look forward to feedback
from the community as well as studies of its implementation to
help inform any future revision of these guidelines.Ethical approval
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(continued )
SCARE Checklist
Topic Item Checklist item description Page Number
10d Complications and adverse or unanticipated events. Described in detail and
ideally categorised in accordance with the Clavien-Dindo Classiﬁcation. How
they were prevented, diagnosed and managed. Blood loss, operative time,
wound complications, re-exploration/revision surgery, 30-day post-op and
long-term morbidity/mortality may need to be speciﬁed.
Discussion 11a Strengths, weaknesses and limitations in your approach to this case. For new
techniques or implants - contraindications and alternatives, potential risks and
possible complications if applied to a larger population. If relevant, has the case
been reported to the relevant national agency or pharmaceutical company (e.g.
an adverse reaction to a device).
11b Discussion of the relevant literature, implications for clinical practice guidelines
and any relevant hypothesis generation.
11c The rationale for your conclusions.
11d The primary “take-away” lessons from this case report.
Patient Perspective 12 When appropriate the patient should share their perspective on the treatments
they received.
Informed Consent 13 Did the patient give informed consent for publication? Please provide if
requested by the journal/editor. If not given by the patient, explain why e.g.
death of patient and consent provided by next of kin or if patient/family
untraceable then document efforts to trace them and who within the hospital is
acting as a guarantor of the case report.
Additional Information 14 Conﬂicts of Interest, sources of funding, institutional review board or ethical
committee approval where required.
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